BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1823968)

  • 21. Haematological complications in polycythaemia vera and thrombocythaemia patients treated with radiophosphorus (32P).
    Randi ML; Fabris F; Varotto L; Rossi C; Macri C; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(3):461-7. PubMed ID: 1703118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered isozyme patterns of leucocyte alkaline phosphatase in disease states.
    Miller DM; Yang A; Liepman M
    Br J Haematol; 1984 May; 57(1):145-54. PubMed ID: 6586202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Molecular diagnosis of chronic myeloproliferative diseases and myelodysplastic syndromes].
    Bock O
    Verh Dtsch Ges Pathol; 2007; 91():140-53. PubMed ID: 18314608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemiluminescence of neutrophils in patients with myeloproliferative or myelodysplastic hematologic diseases--relation to neutrophil alkaline phosphatase activity.
    Wakita H; Asai T; Oh H; Itoh K; Yoshida S
    Intern Med; 1993 Mar; 32(3):204-9. PubMed ID: 7687168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cellular deformability studies in leukemia.
    Sharma K
    Physiol Chem Phys Med NMR; 1993; 25(4):293-7. PubMed ID: 8153154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alkaline phosphatase and peroxidase in goldfish (Carassius auratus) leukocytes.
    Garavini C; Martelli P
    Basic Appl Histochem; 1981; 25(2):133-9. PubMed ID: 7271703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Glycosaminoglycans of human thrombocytes in normal conditions, in chronic myeloid leukosis, myelofibrosis and polycythemia vera].
    Kharchenko MF
    Vopr Med Khim; 1973; 19(6):613-7. PubMed ID: 4277844
    [No Abstract]   [Full Text] [Related]  

  • 29. [Diagnostic value of alkaline leucocyte phosphatase in hematology (author's transl)].
    Pont J; Reimer EE
    Wien Med Wochenschr; 1979 Mar; 129(5):136-9. PubMed ID: 285525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Acquired granulocyte disorders].
    Hakim J; Boivin P; Boucherot J; Troube H
    Nouv Rev Fr Hematol; 1974; 14(2):284-91. PubMed ID: 4136288
    [No Abstract]   [Full Text] [Related]  

  • 31. Breakpoint cluster region, immunoglobulin, and T-cell receptor gene rearrangement analysis in juvenile chronic myelogenous leukemia.
    Farhi DC; Luckey CN; Siddiqui AM
    Mod Pathol; 1995 May; 8(4):389-93. PubMed ID: 7567936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myeloproliferative disorders. Classification and diagnostic features with special emphasis on chronic myelogenous leukemia and agnogenic myeloid metaplasia.
    Hyun BH; Gulati GL; Ashton JK
    Clin Lab Med; 1990 Dec; 10(4):825-38. PubMed ID: 2272176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prognostic value of cytochemical studies in chronic myeloleukemia].
    Shardakov VI; Minakov VN
    Gematol Transfuziol; 1984; 29(5):16-9. PubMed ID: 6329896
    [No Abstract]   [Full Text] [Related]  

  • 34. Monosomy 7 with severe myelodysplasia developing during imatinib treatment of Philadelphia-positive chronic myeloid leukemia: two cases with a different outcome.
    Navarro JT; Feliu E; Grau J; Espinet B; Colomer D; Ribera JM; Oriol A; Granada I; Juncà J; Millá F
    Am J Hematol; 2007 Sep; 82(9):849-51. PubMed ID: 17563075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Levels of fibrinogen degradation products (FDP) and the activity of various granulocytic enzymes].
    Merkiel K; Wołosowicz N; Prokopowicz J
    Acta Haematol Pol; 1986; 17(3-4):110-5. PubMed ID: 3035856
    [No Abstract]   [Full Text] [Related]  

  • 36. Myeloperoxidase cytochemical negativity: an unexpected but intrinsic property of blasts of all phases of chronic myeloid leukemia.
    Anand M; Ghara N; Kumar R; Singh S; Sengar M; Panikar N; Raina V; Sharma A
    Ann Hematol; 2005 Nov; 84(12):767-70. PubMed ID: 15990995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prognostic value of bone marrow biopsy in chronic myeloproliferative disorders].
    Bettini R; Marzetta K; Miglioranza A; Redaelli S; Maino C; Maffiolini A; Gorini M
    Recenti Prog Med; 2003; 94(7-8):314-20. PubMed ID: 12868237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Ferritin in myeloproliferative diseases].
    Aulbert E; Fromm H
    Med Klin (Munich); 1990 Mar; 85(3):125-31. PubMed ID: 2336046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transition of polycythemia vera to chronic myeloid leukaemia.
    Saviola A; Fiorani C; Ferrara L; Mazzocchi V; Zucchini P; Temperani P; Longo G; Emilia G; Torelli G
    Eur J Haematol; 2005 Sep; 75(3):264-6. PubMed ID: 16104886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myeloperoxidase-deficient polymorphonuclear leucocytes. (II) Longitudinal study in acute myeloid leukaemia, untreated, in remission and in relapse.
    Bendix-Hansen K; Nielsen HK
    Scand J Haematol; 1983 Jul; 31(1):5-8. PubMed ID: 6306759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.